Daniel Johnson, MD, is a medical oncologist that specializes in treating patients with melanoma with specific research interests in strategies to overcome immunotherapy resistance and prevent immunotherapy related toxicities. He has multiple peer-reviewed articles and presentations at national meetings pertaining to the management and underlying mechanisms of immune toxicity. Dr. Johnson is a clinical investigator focusing on designing and implementing clinical trials intended to optimize the safety and efficacy of immune checkpoint inhibitors.

Chancellor Donald, MD, is the chief medical officer of the Taking Aim at Cancer in Louisiana initiative. He currently holds the position of assistant professor of clinical medicine at Tulane University. His academic focus is advocacy and health disparities regarding patients with hematologic disorders and malignancy. He previously cared for patients in a community practice at Lourdes Oncology Associates in Lafayette, Louisiana.

Originally from Gretna, Florida, Dr. Donald attended Florida A&M University for undergraduate studies and graduated magna cum laude. He then attended the University of Miami School of Medicine for his medical degree. He completed his internship, residency, and fellowship at Tulane University.

In 2010, he joined Louisiana Oncology Associates, PMC, and became president of the practice in 2014. Dr. Donald would subsequently serve as a lead in crafting a professional services agreement with Our Lady of Lourdes Regional Medical Center, where he served as medical director of the oncology service line, a member of the Medical Executive Committee, and a trustee on the Board of Directors. As medical director, he developed an annual lung cancer screening program using low-dose CT scans for 40 patients yearly at no cost to the patient. In 2013, he was given the Spirit of Hope Award by the American Cancer Society.

Dr. Donald has extended himself beyond his practice to advocate for patients and the appropriate delivery of care. Since 2012 he has served as the hematology representative for Louisiana for the Medicare Carrier Advisory Committee (CAC). He functioned as co-chair of the 2017 and 2018 annual CAC meeting in Washington, D.C. Additionally, he served as a designee to the Program Committee for the 2017 American Society of Hematology Annual Meeting.

He is board certified in internal medicine, hematology, and medical oncology. Most recently, he was appointed to the American Board of Internal Medicine Hematology Examination Committee.

Lauren is a triple board specialized hematologist & medical oncologist. She received her medical education at LSU Health Sciences Center in Shreveport and the Feist Weiller Cancer Center. She is a graduate of Ohio State University and received a Master of Science in Cellular & Molecular Biology at Tulane University prior to her medical pursuits. Her previous experience includes working in forensics and teaching at Delgado Community College. She practices with her husband, Dr. Sanjay Juneja, at the Mary Bird Perkins Cancer Center and Woman's hospital in Baton Rouge with special interest in breast and gynecological tumors. She a proud mother to three young boys.

Dr. Sanjay Juneja is a triple board-certified hematologist & medical oncologist and shortly into his professional career became regarded as a seasoned thought leader for his media presence as the 'TheOncDoc’, where he educates over half a million followers on cancer concepts and the latest therapies through relatable, entertaining content. As the host of the innovative podcast 'Target: Cancer Podcast', Dr. Juneja picks the brains of a wide range of distinguished guests, from Pulitzer Prize winners and selling authors, to celebrities and biomed entrepreneurs. Dr. Juneja has been featured on CNBC, Bloomberg, WebMD, The Washington Post; is an active international Keynote speaker and provides content as a Contributor for Entrepreneur Magazine. In 2022 he co-founded Medfluencers, a health medical specific marketing company named Medical Marketing & Media's 100 Ones to Watch for its focus on effectively utilizing visible healthcare creators in a responsible and compliant manner.

Dr. Juneja has partnered on national education campaigns with the Leukemia Lymphoma Society, Medical Cancer Institute, and DC-based Alliance for Patient Access. In 2022 he was invited by the White House to participate on their Healthcare Leaders in Social Media Roundtable. His accomplishments include being a 2020 Business Reports Forty under 40 award recipient, and in 2023 nominated for the annual ‘Disruptive Innovators in Oncology’ award by Healio and HemOncToday. Dr. Juneja currently practices alongside his wife Lauren at the Mary Bird Cancer Center in Baton Rouge, Louisiana, where they are grateful parents to three vivacious young boys. There, he applies his passion for righting community healthcare inequity and disparities, partnering regularly with the LA Department of Health and Mayor's office to optimize healthcare access and outreach.